by Vita | Oct 12, 2016 | Articles
Key to grades A Strong scientific evidence for this use B Good scientific evidence for this use C Unclear scientific evidence for this use D Fair scientific evidence against this use (it may not work) F Strong scientific evidence...
by Vita | Sep 30, 2016 | Articles
The first automated insulin delivery device for type 1 diabetes has been approved by the U.S. Food and Drug Administration for people aged 14 and older. Often called an “artificial pancreas,” the MiniMed 670G hybrid closed loop system automatically...
by Vita | Jun 2, 2016 | Articles
Ridgefield, Conn., and Indianapolis, May 31, 2016 – The U.S. Food and Drug Administration (FDA) has approved Jentadueto XR (linagliptin and metformin hydrochloride extended-release) tablets for the treatment of type 2 diabetes (T2D) in adults. Jentadueto XR, which is...
